Drug maker Takeda Pharmaceuticals cared more about profits than human safety when it failed to warn consumers that its blockbuster type 2 diabetes drug Actos put users at risk for bladder cancer, argued a plaintiff’s attorney in the second Actos bladder cancer lawsuit to go to trial. The lawsuit was filed by the family of Diep An, who was diagnosed with “high grade bladder cancer” in September 2011, after taking Actos for four years. An died four months after his diagnosis. Attorneys for An’s family argued that Takeda, Asia’s biggest drug maker, knew as early as 2005 that studies had ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.